Table 1.

Baseline characteristics of participants in the European American and African American MVC studies

CharacteristicEuropean AmericanAfrican American
GenotypingGenotypingmRNAMicro RNACortisol
Enrolled, n9489309617280
Age, years, mean (SD)35.6 (13.3)35.1 (12.7)30.5 (10.3)34.6 (11.8)32.3 (10.4)
Females, n (%)575 (60.7)578 (62.2)66 (68.8)107 (62.2)48 (60.0)
Education, n (%)
    8–11 years42 (4.4)71 (7.6)2 (2.0)10 (5.8)11 (13.8)
    High school184 (19.4)290 (31.2)31 (32.3)48 (27.9)29 (36.3)
    Post-high school57 (6.0)42 (4.5)3 (3.1)5 (2.9)5 (6.3)
    Some college312 (32.9)338 (36.3)42 (43.8)77 (44.8)25 (31.3)
    College graduate238 (25.1)137 (14.7)15 (15.6)25 (14.5)7 (8.8)
    Post-graduate studies113 (11.9)36 (3.9)3 (3.1)6 (3.5)3 (3.8)
Overall pain severity, 0–10 NRS, mean (SD)
    Month prior to MVC1.6 (2.6)2.2 (3.3)1.1 (2.4)1.6 (2.9)1.9 (3.2)
    ED5.5 (2.4)7.2 (2.1)7.1 (2.2)7.2 (2.1)7.4 (1.8)
    Week 63.8 (2.8)6.0 (2.9)4.8 (4.1)5.5 (3.4)6.2 (2.5)
Peritraumatic distress in the ED, mean (SD)19.2 (9.9)22.2 (11.6)24.3 (11.6)23.3 (11.5)23.5 (11.5)
  • NRS, Numeric rating scale.